Amarin Corp. Plc (AMRN)
14.17
+0.03
(+0.21%)
USD |
NASDAQ |
Dec 16, 12:25
Amarin Research and Development Expense (Annual): 17.86M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Trinity Biotech Plc | 4.535M |
| Jazz Pharmaceuticals Plc | 884.00M |
| DBV Technologies SA | 89.90M |
| Cellectis SA | 72.02M |
| Akari Therapeutics Plc | 6.986M |